Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Ryan Nelson
“It is simply not in the best interests of our stakeholders to litigate these claims in perpetuity,” says Imerys Talc America President Giorgio La Motta of the company’s decision to reorganize its business and debts under Chapter 11 in negotiation with claimants in cosmetic talc-related suits.
Soleo’s Marum GENtLE THERAPY Shampoo, marketed as an anti-dandruff and hair-growth treatment, is an unapproved new drug, according to FDA. The agency’s warning letter, citing “significant” CGMP violations, follows an August 2018 inspection of the firm’s Pyeongtaek-based facility.
Marketing insiders are denouncing the growing trend of beauty companies weaponing influencers against competing brands. Mary Engle, associate director of FTC’s Division of Advertising Practices, discusses the practice and lines that shouldn’t be crossed, blurry as they may well be.
FDA aims to publish a tentative final monograph for OTC sunscreen drugs in 2019 that identifies “data gaps that FDA believes need to be filled” for 16 currently listed UV filters to support their continued marketing in the US without new drug approvals.
Manufacturers of rinse-off and leave-on cosmetics would have four years and six years, respectively, to comply with ECHA’s proposed restriction on intentionally added microplastics, efforts that ECHA estimates would cost industry around $1.1bn and $7.4bn over 20 years. Microbeads in rinse-off exfoliating/cleansing cosmetics, largely phased out already, would be banned without delay.
Fushi Wellbeing – which markets a range of organic, fresh-pressed face oils derived from the cherry seed, baobab seed and argan nut, among other natural sources – challenged Clinique’s Fresh Pressed line name in light of the brand’s heavy reliance on chemically derived ingredients.